🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — what worked for you? Page 2

MASH prevalence in GLP-1 users — what worked for you?

claudia_zurich Mon, Dec 8, 2025 at 7:23 PM 12 replies 1,032 viewsPage 2 of 3
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Dec 8, 2025 at 10:13 PM#6

Congrats claudia_zurich!! You should be so proud of yourself. 🎉

Last edited: Dec 9, 2025 at 3:13 AM
8 1AttorneyGrant, DebRD_ATL, KristenIndy and 5 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Dec 8, 2025 at 10:30 PM#7

Clinical perspective on MASH prevalence in GLP-1 users what:

I have managed roughly 300 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

6 23InsuranceTom, WendyG_ATL, SaraMom3 and 3 others
Reply Quote Save Share Report
SleepFixSam
Member
212
678
Nov 2024
Hawaii
Dec 8, 2025 at 10:47 PM#8

Same experience here with MASH prevalence in GLP-1. claudia_zurich described it perfectly.

Last edited: Dec 9, 2025 at 12:47 AM
10 6raj_cambridge, ingrid_STO, pete_nash and 7 others
Reply Quote Save Share Report
ChrisMacros
Member
567
2,345
Sep 2024
Michigan
Dec 8, 2025 at 11:04 PM#9

Reading this thread on MASH prevalence in GLP-1 hits close to home. Night shift nurse — I started at 291 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 66 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about MASH prevalence in — take the leap. It was the best health decision I have ever made. ❤️

28 9LibrarianMeg, bri_stats, pete_manc_UK and 25 others
Reply Quote Save Share Report
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Dec 8, 2025 at 11:21 PM#10
Dr.Martinez said:
You should be so proud of yourself

This is exactly right. Dr.Martinez articulated what I have been trying to explain to my friends for months. The MASH prevalence in GLP-1 aspect is what made the difference for me.

25 10BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 22 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register